• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噻唑烷二酮衍生物的合成及生物评价具有高配体效率对 PhzS。

Synthesis and biological evaluation of thiazolidinedione derivatives with high ligand efficiency to PhzS.

机构信息

Programa de Pós-graduação em biotecnologia da, Universidade Estadual de Feira de Santana, Feira de Santana, Brazil.

Faculdade de Farmácia da, Universidade Federal da Bahia, Salvador, Brazil.

出版信息

J Enzyme Inhib Med Chem. 2021 Dec;36(1):1217-1229. doi: 10.1080/14756366.2021.1931165.

DOI:10.1080/14756366.2021.1931165
PMID:34080514
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8186431/
Abstract

The thiazolidinone ring is found in compounds that have widespan biology activity and there is mechanism-based evidence that compounds bearing this moiety inhibit PhzS (PzhS), a key enzyme in the biosynthesis of the virulence factor named pyocyanin. Ten novel thiazolidinone derivatives were synthesised and screened against PhzS, using two orthogonal assays. The biological results provided by these and 28 other compounds, whose synthesis had been described, suggest that the dihydroquinazoline ring, found in the previous hit (- Kd = 18 µM and LE = 0.20), is not required for PzhS inhibition, but unsubstituted nitrogen at the thiazolidinone ring is. The molecular simplification approach, pursued in this work, afforded an optimised lead compound (- 5-(2,4-dimethoxyphenyl)thiazolidine-2,4-dione) with 10-fold improvement in affinity (Kd= 1.68 µM) and more than 100% increase in LE (0.45), which follows the same inhibition mode as the original hit compound (competitive to NADH).Executive summaryPhzS is a key enzyme in the pyocyanin biosynthesis pathway in Orthogonal assays (TSA and FITC) show that fragment-like thiazolidinedione derivatives bind to PhzS with one-digit micromolar affinity.Fragment-like thiazolidinedione derivatives bind to the cofactor (NADH) binding site in PhzS.The molecular simplification optimised the ligand efficiency and affinity of the lead compound.

摘要

噻唑烷酮环存在于具有广泛生物学活性的化合物中,有机制证据表明,含有该部分的化合物抑制 PhzS(PzhS),这是一种毒力因子——绿脓菌素生物合成中的关键酶。合成了十个新的噻唑烷酮衍生物,并使用两种正交测定法对 PhzS 进行了筛选。这些生物结果以及其他 28 种化合物(其合成已被描述)提供的结果表明,先前的命中化合物(- Kd = 18 µM 和 LE = 0.20)中发现的二氢喹唑啉环对于 PzhS 抑制不是必需的,但是噻唑烷酮环上未取代的氮是必需的。在这项工作中,采用了分子简化方法,得到了优化的先导化合物(- 5-(2,4-二甲氧基苯基)噻唑烷-2,4-二酮),亲和力提高了 10 倍(Kd = 1.68 µM),LE 提高了 100%以上(0.45),这与原始命中化合物的抑制模式相同(与 NADH 竞争)。

总结

PhzS 是绿脓菌素生物合成途径中的关键酶。

正交测定法(TSA 和 FITC)表明,类似片段的噻唑烷二酮衍生物与 PhzS 以一位数字微摩尔亲和力结合。

类似片段的噻唑烷二酮衍生物与 PhzS 中的辅酶(NADH)结合位点结合。

分子简化优化了先导化合物的配体效率和亲和力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/b356b113c7e2/IENZ_A_1931165_F0006_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/1a5327118917/IENZ_A_1931165_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/84f9d2c4a6d8/IENZ_A_1931165_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/e8ebde8f4b28/IENZ_A_1931165_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/c8bdec0bc5bf/IENZ_A_1931165_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/bb68266bfc1f/IENZ_A_1931165_F0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/b356b113c7e2/IENZ_A_1931165_F0006_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/1a5327118917/IENZ_A_1931165_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/84f9d2c4a6d8/IENZ_A_1931165_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/e8ebde8f4b28/IENZ_A_1931165_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/c8bdec0bc5bf/IENZ_A_1931165_F0004_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/bb68266bfc1f/IENZ_A_1931165_F0005_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fe2/8186431/b356b113c7e2/IENZ_A_1931165_F0006_B.jpg

相似文献

1
Synthesis and biological evaluation of thiazolidinedione derivatives with high ligand efficiency to PhzS.噻唑烷二酮衍生物的合成及生物评价具有高配体效率对 PhzS。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1217-1229. doi: 10.1080/14756366.2021.1931165.
2
A novel scaffold to fight pyocyanin production: early steps to novel antivirulence drugs.一种新型支架对抗绿脓菌素产生:新型抗毒药物的早期步骤。
Future Med Chem. 2020 Aug;12(16):1489-1503. doi: 10.4155/fmc-2019-0351. Epub 2020 Aug 10.
3
Antimicrobial activity of new 2,4-disubstituted thiazolidinone derivatives.新型 2,4-二取代噻唑烷酮衍生物的抗菌活性。
Z Naturforsch C J Biosci. 2009 Nov-Dec;64(11-12):785-9. doi: 10.1515/znc-2009-11-1205.
4
Green Synthesis, Biological Activity Evaluation, and Molecular Docking Studies of Aryl Alkylidene 2, 4-thiazolidinedione and Rhodanine Derivatives as Antimicrobial Agents.芳基亚烷基-2,4-噻唑烷二酮和若丹宁衍生物作为抗菌剂的绿色合成、生物活性评价及分子对接研究
Comb Chem High Throughput Screen. 2019;22(10):716-727. doi: 10.2174/1386207322666191127103122.
5
1-1,2,3-triazol-1,4-naphthoquinone Derivatives: Novel Inhibitors Targeting Pyocyanin Biosynthesis for Infection Treatment Advances.1-1,2,3-三唑-1,4-萘醌衍生物:针对绿脓菌素生物合成的新型抗感染治疗靶点抑制剂的研究进展。
Curr Top Med Chem. 2024;24(24):2161-2171. doi: 10.2174/0115680266327024240726111230.
6
Synthesis and Biological Evaluation of Coumarins Derivatives as Potential Inhibitors of the Production of Pseudomonas aeruginosa Virulence Factor Pyocyanin.香豆素衍生物的合成及生物评价及其作为铜绿假单胞菌毒力因子绿脓菌素产生抑制剂的潜力。
Curr Top Med Chem. 2018;18(2):149-156. doi: 10.2174/1568026618666180329122704.
7
Synthesis, Anticancer, and Antibacterial Studies of Benzylidene Bearing 5-substituted and 3,5-disubstituted-2,4-Thiazolidinedione Derivatives.苯亚甲基含 5-取代和 3,5-二取代-2,4-噻唑烷二酮衍生物的合成、抗癌和抗菌研究。
Med Chem. 2021;17(4):369-379. doi: 10.2174/1573406416666200512073640.
8
Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.降低多重耐药铜绿假单胞菌毒力因子绿脓菌素的产生。
J Infect Chemother. 2013 Feb;19(1):82-8. doi: 10.1007/s10156-012-0457-9. Epub 2012 Aug 3.
9
Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.一些新型N-取代5-亚苄基-2,4-噻唑烷二酮的合成、HIV-1逆转录酶抑制、抗菌、抗真菌及结合模式研究
Daru. 2015 Jan 24;23(1):6. doi: 10.1186/s40199-014-0086-1.
10
Evaluating the Antivirulence Effects of New Thiazolidinedione Compounds Against PAO1.评估新型噻唑烷二酮化合物对 PAO1 的抗毒力作用。
Microb Drug Resist. 2022 Nov;28(11):1003-1018. doi: 10.1089/mdr.2022.0134. Epub 2022 Oct 10.

引用本文的文献

1
Updates on therapeutic targeting of diguanylate cyclase for addressing bacterial infections: A comprehensive review.针对细菌感染的二鸟苷酸环化酶治疗靶点的最新进展:全面综述
World J Microbiol Biotechnol. 2025 Aug 26;41(9):317. doi: 10.1007/s11274-025-04512-6.
2
1-1,2,3-triazol-1,4-naphthoquinone Derivatives: Novel Inhibitors Targeting Pyocyanin Biosynthesis for Infection Treatment Advances.1-1,2,3-三唑-1,4-萘醌衍生物:针对绿脓菌素生物合成的新型抗感染治疗靶点抑制剂的研究进展。
Curr Top Med Chem. 2024;24(24):2161-2171. doi: 10.2174/0115680266327024240726111230.
3
Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

本文引用的文献

1
A novel scaffold to fight pyocyanin production: early steps to novel antivirulence drugs.一种新型支架对抗绿脓菌素产生:新型抗毒药物的早期步骤。
Future Med Chem. 2020 Aug;12(16):1489-1503. doi: 10.4155/fmc-2019-0351. Epub 2020 Aug 10.
2
An Analysis of Antibacterial Drug Development Trends in the United States, 1980-2019.美国 1980-2019 年抗菌药物研发趋势分析。
Clin Infect Dis. 2021 Dec 6;73(11):e4444-e4450. doi: 10.1093/cid/ciaa859.
3
Antileishmanial activity evaluation of thiazolidine-2,4-dione against Leishmania infantum and Leishmania braziliensis.
针对病原菌群体感应、生物膜形成和抗生素耐药性的“神圣三角”
Microorganisms. 2022 Jun 16;10(6):1239. doi: 10.3390/microorganisms10061239.
4
Antifungal Thiazolidines: Synthesis and Biological Evaluation of Mycosidine Congeners.抗真菌噻唑烷类:霉菌定类似物的合成与生物学评价
Pharmaceuticals (Basel). 2022 May 1;15(5):563. doi: 10.3390/ph15050563.
噻唑烷-2,4-二酮类化合物抗利什曼原虫婴儿利什曼原虫和巴西利什曼原虫的抗利什曼活性评价。
Parasitol Res. 2020 Jul;119(7):2263-2274. doi: 10.1007/s00436-020-06706-3. Epub 2020 May 27.
4
Antibacterial Discovery: 21st Century Challenges.抗菌药物发现:21世纪的挑战
Antibiotics (Basel). 2020 Apr 28;9(5):213. doi: 10.3390/antibiotics9050213.
5
Cladodionen Is a Potential Quorum Sensing Inhibitor Against .克拉多菌素是一种潜在的群体感应抑制剂,可抑制 。
Mar Drugs. 2020 Apr 10;18(4):205. doi: 10.3390/md18040205.
6
Synthesis and Antimicrobial Activity of a New Series of Thiazolidine-2,4-diones Carboxamide and Amino Acid Derivatives.新型噻唑烷-2,4-二酮羧酸酰胺和氨基酸衍生物的合成及抑菌活性。
Molecules. 2019 Dec 27;25(1):105. doi: 10.3390/molecules25010105.
7
Discovery of an antivirulence compound that reverses β-lactam resistance in MRSA.发现一种抗毒化合物,可逆转耐甲氧西林金黄色葡萄球菌(MRSA)的β-内酰胺类抗生素耐药性。
Nat Chem Biol. 2020 Feb;16(2):143-149. doi: 10.1038/s41589-019-0401-8. Epub 2019 Nov 25.
8
Pseudomonas aeruginosa quorum sensing inhibition by clinical isolate Delftia tsuruhatensis 11304: involvement of N-octadecanoylhomoserine lactones.临床分离株 Delftia tsuruhatensis 11304 对铜绿假单胞菌群体感应的抑制作用:涉及 N-十八碳酰高丝氨酸内酯。
Sci Rep. 2019 Nov 11;9(1):16465. doi: 10.1038/s41598-019-52955-3.
9
Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity.含氮侧链的苯并噻唑类化合物:克服分子肥胖的一种方法。
Eur J Med Chem. 2019 Nov 15;182:111593. doi: 10.1016/j.ejmech.2019.111593. Epub 2019 Aug 10.
10
Targeting virulence factors as an antimicrobial approach: Pigment inhibitors.作为一种抗菌方法的靶向毒力因子:色素抑制剂。
Med Res Rev. 2020 Jan;40(1):293-338. doi: 10.1002/med.21621. Epub 2019 Jul 2.